Technological development of oligosaccharide units as biomaterials of life science

低聚糖单元作为生命科学生物材料的技术进展

基本信息

  • 批准号:
    09556021
  • 负责人:
  • 金额:
    $ 7.3万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    1997
  • 资助国家:
    日本
  • 起止时间:
    1997 至 1999
  • 项目状态:
    已结题

项目摘要

Our purpose is to prepare oligosaccharide units library folowing practical synthesis of biologically important oligosaccharides essentially for developing glycobology and glycottechnolog. The synthesis of possible array of linkages of (1-3), (1-4) and (1-6) of β-D-Gal-D-GlcNAc and β-D-Gal-D-GalNAc was done by using some readily available β-D-galactosidases. The preparation of the galactosyl-disaccharide units library led to the enzymatic synthesis of trisaccharides containing GlcNAc; β-D-GlcNAc-(1-3)-β-D-Gal-(1-4)-GlcNAc as a common unit of polylacto- saminoglycan and β-D-Gal-(1-3)-[β-D-GlcNAc-(1-6)]-α-D-GalNAc-OCィイD26ィエD2HィイD24ィエD2NOィイD22ィエD2-p as a carbohydrate unit of mucin type 2 core. Transglycosylation of L-Fuc to LacNAc and lactose utilizing α-L-fucosidases also produced α-L-fucosyl-N-acetyllactosamine and 3'-O-α-L-fucosyllactose. Furthermore, as a synthetic strategy of human milk oligosaccharide, lacto-N-tetraose (β-D-Gal-(1-3)-β-D-GlcNAc-(1-3)-β-D-Gal-(1-4)-D-Glc)and lacto-N-neotetraose(β-D-Gal-(1-4)-β-D-GlcNAc-(1-3)-β-D-Gal-(1-4)-D-Glc) were practically synthesized by a combination of glycosyltransferase catalyzed reaction and glycosidase-catalyzed transglycosylation from lactose as an initial substance.Such synthetic oligosaccharides available in large amounts were used to synthesize glycopolymer. chemo-enzymatic synthesis of glycopeptides carrying LacNAc unit as a model of asialoglycoprotein, and β-D-Gal-(1-3)-α-D-GalNAc and α-NeuAc-(1-3)-β-D-Gal-(1-3)-α-D-GalNAc units as models of mucin-type glycoproteins was carried out by introducing these oigosaccharides as side chain into polyglutamic acid as main chain. The artgificial glycopolypeptides were shown to be useful as probes of carbohydrate recognition and modeling in the analysis of glycoprotein-lectin interactions.
我们的目的是在实际合成具有重要生物学意义的低聚糖后,制备低聚糖单元库,主要用于糖学和糖技术的发展。利用一些现成的β- d -半乳糖苷酶合成了β-D-Gal-D-GlcNAc和β-D-Gal-D-GalNAc的(1-3)、(1-4)和(1-6)可能的键阵。半乳糖-二糖单元库的制备导致了含GlcNAc的三糖的酶促合成;β-D-GlcNAc-(1-3)-β-D-Gal-(1-4)- glcnac是聚乳酸-氨基聚糖的共同单位,β-D-Gal-(1-3)-[β-D-GlcNAc-(1-6)]-α- d - galnac - oc是粘蛋白2型核的碳水化合物单位。利用α-L- focusidase将L-Fuc转糖基化为LacNAc和乳糖也产生α-L- focusyl- n -乙酰乳胺和3'- o -α-L- focusyllactose。此外,作为人乳低聚糖的合成策略,以乳糖为起始物质,通过糖基转移酶催化反应和糖苷酶催化转糖基化反应,实际合成了乳酸-n -四糖(β-D-Gal-(1-3)-β- d - glcnac -(1-3)-β-D-Gal-(1-4)- (1-4)- d - glc)和乳酸-n -新四糖(β-D-Gal-(1-4)- β-D-Gal-(1-3)- β-D-Gal-(1-4)- d - glc)。这种合成的低聚糖大量可用来合成糖共聚物。将低聚糖作为侧链引入聚谷氨酸作为主链,以LacNAc单元为asialalprotein模型,以β-D-Gal-(1-3)-α- d - galnac和α-NeuAc-(1-3)-β-D-Gal-(1-3)-α- d - galnac单元为黏液型糖蛋白模型的糖肽进行化学酶合成。人工糖共肽在糖蛋白-凝集素相互作用分析中被证明是有用的碳水化合物识别和建模探针。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
T.Murata, T.Usui et al: "Facile enzymatc conversion of lactose into lacto-N-tetraose and lacto-N-tetraose"Glycoconjugate Journal. 16. 189-195 (1999)
T.Murata、T.Usui 等人:“将乳糖轻松酶促转化为乳糖-N-四糖和乳糖-N-四糖”糖复合物杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Murata,T.,Shimada M.,Watanabe N.,Sakata K.,and Usui T.: "Practical enzymatic synthesis of primeverose annd its glycoside"J.Appl.Glycosci.. 46. 431-437 (1999)
Murata,T.,Shimada M.,Watanabe N.,Sakata K.,and Usui T.:“春花及其糖苷的实用酶促合成”J.Appl.Glycosci.. 46. 431-437 (1999)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
T. Murata, T. Inukai, T. Suzuki, S. M. Yamagishi and T. Usui: "Facile enzymatc conversion of lactose into lacto-N-tetraose and lacto-N-tetraose"Glycoconjugate J.. 16. 189-195 (1999)
T. Murata、T. Inukai、T. Suzuki、S. M. Yamagishi 和 T. Usui:“将乳糖轻松酶促转化为乳糖-N-四糖和乳糖-N-四糖”Glycoconjugate J.. 16. 189-195 (1999)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
T. Murata, T. Itoh and T. Usui: "Enzymatic synthesis of β-D-Gal-(1-3)-[β-D-GlcNAc-(1-6)]-α-D-GalNAc-OCィイD26ィエD2HィイD24ィエD2NOィイD22ィエD2-pas a carbohydrate unit of mucin-type 2 core"Glycoconjugate J.. 15. 575-582 (1998)
T. Murata、T. Itoh 和 T. Usui:“β-D-Gal-(1-3)-[β-D-GlcNAc-(1-6)]-α-D-GalNAc-OC 的酶促合成” D26 D2H D24 D2NO D22 D2-pas 粘蛋白型 2 核心的碳水化合物单元”Glycoconjugate J.. 15. 575-582 (1998)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
T. Usui: ""Synthesis of glycan chain using enzyme" (in Japanese)""Research of biological active glycan" ed by Gakaishuppan center.
T. Usui:“利用酶合成聚糖链”(日语)“生物活性聚糖的研究”,Gakaishuppan 中心编辑。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

USUI Taichi其他文献

USUI Taichi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('USUI Taichi', 18)}}的其他基金

Preparation of novel material as adhesive biomatrix by devising oligosaccharide units
通过设计寡糖单元制备作为粘附生物基质的新型材料
  • 批准号:
    13556017
  • 财政年份:
    2001
  • 资助金额:
    $ 7.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Simulation of functional glycomolecule as carbohydrate model on cell surface
细胞表面功能糖分子作为碳水化合物模型的模拟
  • 批准号:
    11660105
  • 财政年份:
    1999
  • 资助金额:
    $ 7.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Preparation of Oligosaccharaide Units Library Involved in Glycoconjugate and Its Utilization
复合糖低聚糖单元库的制备及其应用
  • 批准号:
    08660134
  • 财政年份:
    1996
  • 资助金额:
    $ 7.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Glycotechnological Studies on Oligosaccharide Units Involved in Molecular Recognition.
参与分子识别的寡糖单元的糖技术研究。
  • 批准号:
    06808055
  • 财政年份:
    1994
  • 资助金额:
    $ 7.3万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
Regioselective Synthesis of Sugar-chain Unit Involved in Glycoconjugate by Glycosidase
糖苷酶区域选择性合成糖复合物中涉及的糖链单元
  • 批准号:
    02806017
  • 财政年份:
    1990
  • 资助金额:
    $ 7.3万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
Studies on Novel Syntheses of Useful Carbohydrates by Enzyme Hybrid
杂化酶新型合成有用碳水化合物的研究
  • 批准号:
    63560124
  • 财政年份:
    1988
  • 资助金额:
    $ 7.3万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
Production of Useful Oligosaccharides by Lytic Enzymes
通过裂解酶生产有用的低聚糖
  • 批准号:
    61560138
  • 财政年份:
    1986
  • 资助金额:
    $ 7.3万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

Regenerative biomaterial patches for failing hearts
用于衰竭心脏的再生生物材料贴片
  • 批准号:
    MR/X024210/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.3万
  • 项目类别:
    Fellowship
System for Annulus Fibrosus Repair (SAFR) – a percutaneously implantable preformed biomaterial for the repair of defects caused by either degenerative disc disease or needle puncture during nucleus pulposus replacement procedures SAFR
纤维环修复系统 (SAFR) — 一种可经皮植入的预制生物材料,用于修复髓核置换手术期间因椎间盘退行性疾病或针刺造成的缺陷
  • 批准号:
    10051703
  • 财政年份:
    2023
  • 资助金额:
    $ 7.3万
  • 项目类别:
    Collaborative R&D
A human tissue-engineered three-layer cornea (hTEC) supplemented with macrophages as a biomaterial for in vitro studies
补充有巨噬细胞的人体组织工程三层角膜(hTEC)作为体外研究的生物材料
  • 批准号:
    488980
  • 财政年份:
    2023
  • 资助金额:
    $ 7.3万
  • 项目类别:
    Operating Grants
Development of a novel biomaterial model of collagen mediated genetic disease for study of collagen organisation and drug development
开发胶原蛋白介导的遗传病的新型生物材料模型,用于研究胶原蛋白组织和药物开发
  • 批准号:
    2897511
  • 财政年份:
    2023
  • 资助金额:
    $ 7.3万
  • 项目类别:
    Studentship
SBIR Phase I: A Novel Carbon-Sequestering Biomaterial for Dropped Ceiling Tiles
SBIR 第一阶段:用于吊顶瓷砖的新型碳封存生物材料
  • 批准号:
    2304384
  • 财政年份:
    2023
  • 资助金额:
    $ 7.3万
  • 项目类别:
    Standard Grant
Immunomodulatory biomaterial to enhancing T-cell responses to triple negative breast cancer
免疫调节生物材料可增强 T 细胞对三阴性乳腺癌的反应
  • 批准号:
    10699815
  • 财政年份:
    2023
  • 资助金额:
    $ 7.3万
  • 项目类别:
Bacterial Adhesion Inhibition and Biofilm Disruption by Adaptive Piezoelectric Biomaterial
自适应压电生物材料抑制细菌粘附和破坏生物膜
  • 批准号:
    10668030
  • 财政年份:
    2023
  • 资助金额:
    $ 7.3万
  • 项目类别:
Highly Elastic Biomaterial Development for Urethral Application
尿道应用的高弹性生物材料开发
  • 批准号:
    10573094
  • 财政年份:
    2023
  • 资助金额:
    $ 7.3万
  • 项目类别:
Biomaterial Manufacturing Suite in Support of NIH/NIAID and the Global Infectious Disease Research Community
支持 NIH/NIAID 和全球传染病研究界的生物材料制造套件
  • 批准号:
    10795293
  • 财政年份:
    2023
  • 资助金额:
    $ 7.3万
  • 项目类别:
Mitigating the Immunogenicity of Engineered Aav Gene Delivery Vectors by Biomaterial-Driven Immunosuppression
通过生物材料驱动的免疫抑制减轻工程化 Aav 基因递送载体的免疫原性
  • 批准号:
    10741139
  • 财政年份:
    2023
  • 资助金额:
    $ 7.3万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了